Arrowstreet Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.9M Buy
1,569,491
+66,874
+4% +$1.6M 0.02% 595
2025
Q4
$40.1M Sell
1,502,617
-146,247
-9% -$3.49M 0.02% 538
2025
Q3
$35.2M Buy
1,648,864
+1,312,426
+390% +$31M 0.02% 559
2025
Q2
$7.26M Buy
+336,438
New +$6.25M 0.01% 1012
2023
Q4
Sell
-54,901
Closed -$1.14M 1383
2023
Q3
$1.14M Buy
+54,901
New +$1.49M ﹤0.01% 955
2022
Q3
Sell
-61,099
Closed -$861K 1246
2022
Q2
$861K Buy
+61,099
New +$1.14M ﹤0.01% 966
2021
Q1
Sell
-6,100
Closed -$326K 2203
2020
Q4
$326K Sell
6,100
-137,661
-96% -$6.83M ﹤0.01% 2103
2020
Q3
$5.93M Sell
143,761
-142,373
-50% -$6.15M 0.01% 1080
2020
Q2
$13.9M Buy
286,134
+253,134
+767% +$12.2M 0.03% 647
2020
Q1
$1.39M Sell
33,000
-614,248
-95% -$25.3M ﹤0.01% 1195
2019
Q4
$27.7M Buy
+647,248
New +$28.2M 0.06% 309

Other funds holding ACAD